Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 75Carcinoma, Non-Small-Cell Lung 68Multiple Myeloma 55Prostatic Neoplasms 54Leukemia, Myeloid, Acute 44Colorectal Neoplasms 44Neoplasms 40Ovarian Neoplasms 36Lymphoma 33Melanoma 31Neoplasm Metastasis 30Lymphoma, Non-Hodgkin 30Sarcoma 29Lung Neoplasms 28Endometrial Neoplasms 27Squamous Cell Carcinoma of Head and Neck 26Recurrence 25Pancreatic Neoplasms 25Carcinoma, Hepatocellular 25Glioma 23Leukemia, Lymphocytic, Chronic, B-Cell 22Hodgkin Disease 22Urinary Bladder Neoplasms 21Lymphoma, Large B-Cell, Diffuse 21Head and Neck Neoplasms 21Carcinoma, Renal Cell 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Myelodysplastic Syndromes 20Brain Neoplasms 18Hematologic Neoplasms 17

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1blinatumomab 1Thiotepa 1Mesna 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Large Granular Lymphocytic × 30 days × Clear all
NCT03849651 2026-06-03

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
69 enrolled 17 charts
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡